ArticleBMC cancer2019
Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
Moire Cuncannon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it